JB Chemicals & Pharmaceuticals Limited — Updates, 14-05-2025: Press Release

JB Chemicals & Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year. Revenue grew 10% to INR 949 Cr in Q4 and 12% to INR 3918 Cr for FY25. Net profit increased 15% to INR 146 Cr in Q4 and 19% to INR 660 Cr for FY25. Domestic formulations drove growth with 11% in Q4 and 20% for FY25, led by chronic and acute segments. The CDMO business recovered strongly in H2, boosting margins and profitability. Net cash stands at INR 689 Cr with ROCE at 32%.